Legal

Search documents
Deadline Alert: Fortinet, Inc. (FTNT) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Businesswire· 2025-09-26 16:37
On this news, Fortinet's stock price fell $21.28, or 22%, to close at $75.30 per share on August 7, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the refresh cycle would neve ...
FSFG Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of First Savings Financial Group, Inc. Is Fair to Shareholders
Businesswire· 2025-09-25 14:50
Sep 25, 2025 10:50 AM Eastern Daylight TimeFSFG Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of First Savings Financial Group, Inc. Is Fair to ShareholdersShareNEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of First Savings Financial Group, Inc. (NASDAQ: FSFG) to First Merchants Corporation for 0.85 of a share of First Merchants common stock per share of First Savings common stock is fair to First Savings shareholders.Halper Sad ...
Law Offices of Frank R. Cruz Encourages Fluor Corporation (FLR) Investors To Inquire About Securities Fraud Class Action
Businesswire· 2025-09-22 16:09
Sep 22, 2025 12:09 PM Eastern Daylight Time Law Offices of Frank R. Cruz Encourages Fluor Corporation (FLR) Investors To Inquire About Securities Fraud Class Action Share LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Fluor Corporation ("Fluor†or the "Company†) (NYSE: FLR) securities between February 18, 2025 and July 31, 2025, inclusive (the "Class Period†). Fluor investors have until November 14, ...
Deadline Approaching: Fly-E Group, Inc. (FLYE) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Businesswire· 2025-09-16 17:44
Core Viewpoint - Fly-E Group, Inc. is facing a class action lawsuit due to significant financial losses and misleading statements made by the company regarding its business operations and prospects during the class period from July 15, 2025, to August 14, 2025 [3][5]. Financial Performance - On August 14, 2025, Fly-E reported a 32% year-over-year decline in net revenues, primarily attributed to decreased unit sales following multiple lithium-battery accidents involving its E-Bikes and E-Scooters [3]. - Following this announcement, Fly-E's stock price plummeted by $6.76, or 87.1%, closing at $1.00 per share on August 15, 2025, resulting in significant losses for investors [4]. Legal Proceedings - A class action lawsuit has been filed alleging that Fly-E's management made materially false and misleading statements about the company's brand reputation, cost reductions, and the risks associated with lithium batteries, which misled investors about the company's true financial health [5]. - Investors who purchased Fly-E securities during the class period are encouraged to file a lead plaintiff motion by the deadline of November 7, 2025, if they meet certain legal requirements [6].
Flywire Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FLYW
Businesswire· 2025-09-05 17:27
Core Viewpoint - Flywire Corporation is facing a class action lawsuit for alleged violations of securities laws, specifically for making false and misleading statements regarding its revenue growth and the impact of visa restrictions on its business [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 28, 2024, to February 25, 2025, with a deadline for lead plaintiff appointments set for September 23, 2025 [2]. - The complaint alleges that Flywire exaggerated the sustainability of its revenue growth and misled investors about the negative impacts of visa and permit restrictions [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the specified class period are encouraged to contact the DJS Law Group for potential participation in the lawsuit [2][3]. - There is no cost or obligation for shareholders to participate, and they will be enrolled in a portfolio monitoring software for updates on the case [3]. Group 3: Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4]. - The firm emphasizes the importance of respecting and focusing on the litigation claims of its clients, which are considered valuable assets [4].
Knowledge Graphs in Litigation Agents — Tom Smoker, WhyHow
AI Engineer· 2025-07-22 17:00
Core Argument - Structured Representations, emphasizing relationships between clauses, documents, entities, and parties, are crucial in the legal field [1] - Structured Context Injection, enabled by Structured Representations, enhances context and reduces hallucinations in legal agents [1] Case Studies & Applications - The report highlights production systems built for legal use-cases, including recursive contractual clause retrieval and HITL legal reasoning news agents [1] - These systems demonstrate the significant improvement in effectiveness and reliability of legal agents through structured representations [1] Key Technologies - Structured Representations are presented as a key technology for improving legal agents [1]
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel
Globenewswire· 2025-03-07 21:09
Group 1 - Tevogen Bio, a clinical-stage specialty immunotherapy biotech company, is leveraging AI to enhance precision medicine and operational efficiencies [2][3][5] - The company has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets, including three granted patents and multiple pending patents related to AI [5][6] - Tevogen Bio aims to make advanced therapies more accessible and affordable by combining proprietary datasets with generative AI models [3][5] Group 2 - The recent AI discussion panel featured industry leaders discussing the transformative impact of AI across finance, biotech, and legal sectors [2][4] - The event highlighted the importance of tailoring AI applications to address unique challenges within each industry [3][4] - Tevogen Bio's leadership emphasizes the need for disruptive business models to sustain medical innovation and ensure patient accessibility [5][6]